DUSP6 was shown to be downregulated in AD (Banzhaf-Strathmann et al., 2014), so we hypothesized that DUSP6 overexpression would mitigate AD-associated neuropathology by upregulating expression of genes in the VGF gene network, including VGF. The gene discussed is DUSP6; the disease is Alzheimer disease.